Mergers - Acquisitions News: Breaking Mergers - Acquisitions News, Comments and Articles. - Page: 3

2 BioPharma Catalyst Trades And 1 Strong Acquisition Target Rumored To Be In Play

By Scott Matusow:Today, we look at two companies with significant short-term catalysts quickly approaching, and one company that could be acquired before the year is over. Catalyst trades can be very lucrative, with several ways to trade them. For example, one can use the option chain to buy calls, effectively making a bet the stock will hit a certain price range by a given date. This allows trade...

Global Critical Care Market Will Reach $3.2 Billion in 2019 - Growth from Factor Concentrates, New Indications and Increasing Demand for Albumin in Asia-Pacific

MarketResearchReports.Biz announces addition of new report “Global Critical Care Market to 2019” to its database. Buy the copy of this report visit - http://www.marketresearchreports.biz/analysis-details/critical-care-market-to-2019-growth-from-factor-concentrates-new-indications-and-increasing-demand-for-albumin-in-asia-pacific Albany, NY (PRWEB) May 15, 2013 GBI Research, the leading busine...

Cathy Guibal Named Principal at Sullivan, Cotter and Associates, Inc.

Sullivan, Cotter and Associates, Inc., one of the nation’s leading independent compensation, benefits and human resources management consulting firms, has named Cathy Guibal as a Principal in the Physician Compensation Practice. Based in Denver, Cathy will be building Client relationships and supporting SullivanCotter’s national Physician Compensation...

Latteno's Subsidiary Green Cannabis Introduces Medical Marijuana Edible Products

SANTA ANA, Calif., May 14, 2013 /PRNewswire/ -- Latteno Food Corp.'s (OTCPink: LATF) wholly-owned subsidiary Green Cannabis, today announced the release of new roll-out medical marijuana edible products consisting of our own private label Peanut Butter Cup, Chocolate Bar and Chocolate Chip Cookie all made out of Cannabutter.  These are Endocannabinoid CBD Edibles: Peanut Butter Cups consist...

J.P. Fingado Selected as 2013 Bravo! Entrepreneur Award Winner

API Healthcare President and Chief Executive Officer recognized by BizTimes for exceptional leadership that drives the company’s growth and innovation strategies API Healthcare, architect of the revolutionary Healthcare Workforce Information Exchange (HwIE), today announced that President and Chief Executive Officer, J.P. Fingado was selected by...

Lucintel Profiles Leaders in Generic Drugs Industry: Global Market Expected to Reach US $335.8 Billion in 2017

Lucintel profiles leaders in generic drugs industry: global market expected to reach US $335.8 Billion in 2017 Irving, TX (PRWEB) May 14, 2013 Top companies are making strategic acquisitions to expand their global footprint, together with taking advantage of established business and expertise gained through the acquired company. The global generic drugs industry experienced average growth over th...

Simulations Plus Software Used in Regulatory Submittals

US FDA, UK MHRA, and European EMA Accept Simulation Results in Applications Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that results of simulations using its GastroPlus™ software have been submitted to major regulatory agencies as part of...

Opus Bank Announces Launch of New Healthcare Banking Division

− Evan Barker Joins Opus Bank as Senior Managing Director, Healthcare Banking − Opus Bank (“Opus” or the “Bank”) announced today the formation of its Healthcare Banking division, a new niche focus within Opus’ Commercial Business Banking division. The new division will initially focus on providing capital financing and banking solutions t...

Allergan's Global Dominance in Facial Injectables Challenged by Acquisitions and Partnership Agreements Among Competitors

TORONTO, May 14, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Allergan continues to dominate the global facial injectable market but is facing increasing competition from a growing number of competitors. As the traditional leader in this market, Allergan earned its top position primarily through its lon...

Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2013 First Quarter Earnings Conference Call on Thursday, May 16, 2013 at 9:00 a.m. ET

XIANYANG, China, May 14, 2013 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that management will hold a conference call to discuss its 2013 first quarter performance at 9:00 a.m. ET on Thurs...

Catholic-secular hospital mergers further complicate crowded abortion-rights battlefield

Mergers between Catholic and secular hospitals could mean wider restriction of abortion, even as lawmakers in many states consider tighter regulation or bans on the procedure.

Merus Labs International Inc. Announces Second Quarter Results for Fiscal 2013

TORONTO, ONTARIO -- (Marketwired) -- 05/14/13 -- Merus Labs International Inc. ("Merus" or the "Company") (TSX: MSL)(NASDAQ: MSLI) is pleased to announce today its financial results for the second quarter of fiscal 2013. The results from the second quarter of fiscal 2013, for both revenue and earnings, have exceeded management's expectations. For the three months ended March 31, 2013, the Compa...

Covidien Announces Pricing of $750 Million Senior Notes Offering

Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), priced an underwritten offering of $750 million aggregate principal amount of 2.950% senior notes due 2023. The offering is expected to close on May 16, 2013. These notes are fully and unconditionally guaranteed on a senior...

Cadwalader Advises Elan Corporation in Billion Dollar Royalty Deal

NEW YORK, May 13, 2013 /PRNewswire/ -- Cadwalader, Wickersham & Taft LLP, a leading counselor to global financial institutions and corporations, announced today that client Elan Corporation, plc, a biotechnology company headquartered in Ireland, will purchase from Theravance, Inc. a 21% participation interest in potential future royalty payments related to four respiratory program...

Covance To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference

PRINCETON, N.J., May 13, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15, 2013 at 11:00 a.m. (ET).  Investors may access a live webcast of the presentation at www.covance.com.  In order to register and download any necessary software, please log on 10 minutes earl...

Catholic-Secular Hospital Mergers Further Complicate Abortion-Rights Battlefield

Mergers between Catholic and secular hospitals could mean wider restriction of abortion, even as lawmakers in many states consider tighter regulation or bans on the procedure. The New York Times: Hospital Mergers Reset Abortion-Access Battle Politicians seeking to restrict access to abortion, a marked trend this year from North Dakota to Arkansas, tend not to get much traction in [Washington stat...

Covidien Announces Senior Notes Offering

Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), launched an underwritten offering of senior notes. These notes will be fully and unconditionally guaranteed on a senior unsecured basis by Covidien plc and its subsidiary, Covidien Ltd. CIFSA intends to use the proceeds from the of...

Biologix Hair Inc. Appoints Ken Zadoorian to Board of Directors

TORONTO, ONTARIO -- (Marketwired) -- 05/13/13 -- Biologix Hair Inc. (OTCBB: BLGX) (OTCQB: BLGX) has appointed Ken Zadoorian to the Company's Board of Directors. Mr. Zadoorian will serve as an independent, non-executive Director. Ken Zadoorian has built a long track record as a successful executive with an extensive background in large organizations and smaller start-ups as well as experience man...

2013 Holds Promise For Mergers & Acquisitions – Kline

Researchers from Kline and Company predict 2013 will be a big year for M&A activity, and lay out a list of smaller companies that could be prime targets.

Diagnostic Imaging International Corp. 2013 Q1 Financial Results

LAS VEGAS, NEVADA -- (Marketwired) -- 05/13/13 -- Diagnostic Imaging International Corp. (OTCQB: DIIG) announced today that it has filed its 10-Q report for the first quarter of 2013. The Company is very pleased to report that it has generated record revenues in Q1 2013. The Company is now looking to expand operations through additional acquisitions. The Company will require financing in order...

Misonix Appoints Stavros Vizirgianakis to Board of Directors

FARMINGDALE, N.Y., May 10, 2013 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced today that Mr. Stavr...

Valeant Pharmaceuticals: Don't Take Profits Yet, Still Room To Grow In 2013

By Jeffrey To:Valeant Pharmaceuticals (NYSE:VRX) is a $22.5 billion pharmaceutical company that focuses on developing and distributing medicines for dermatology, neurology and other infectious diseases. It is trading at $72.81, near the top of its 52-week range of $42.47-$76.57 due to management's aggressive growth strategies. Valeant's expansion has been mainly driven by acquisitions, and I expec...

Pernix Therapeutics Reports First Quarter 2013 Financial Results

Revenues Increased 52% to $22.1 million compared to $14.5 million in the First Quarter 2012 Completed Acquisition of Somaxon in March 2013 Michael Pearce, Chairman of the Board, appointed President and Chief Executive Officer Cooper Collins appointed Chief Strategic Officer and remains on the Board of Directors...

Sirona Announces Additional $100 Million Share Repurchase Authorization

Sirona (Nasdaq: SIRO), the dental technology leader, today announced that the Company's Board of Directors has approved a new share repurchase program, authorizing up to an additional $100 million in share repurchases, with an expiration date of June 30, 2016. This amount is in addition to the $7.4 million remaining as of March 31, 2013 from our prior $100...

Healthcare Corporation of America Names Public-Company Veteran Yoram Bibring as Chief Financial Officer

DENVILLE, N.J., May 10, 2013 /PRNewswire/ -- Healthcare Corporation of America (OTCBB: SWCAL), a pharmacy-benefit management company, has named Yoram Bibring its chief financial officer, effective June 3. Mr. Bibring's appointment comes a month after HCCA became a public company through its acquisition by Selway Capital Acquisition Corp. "HCCA is undergoing an exciting transformation as a...